Revance Therapeutics
RVNC
#7076
Rank
NZ$0.66 B
Marketcap
$6.37
Share price
-2.86%
Change (1 day)
-47.40%
Change (1 year)

Market capitalization of Revance Therapeutics (RVNC)

Market cap: NZ$0.66 Billion

As of November 2024 Revance Therapeutics has a market cap of NZ$0.66 Billion. This makes Revance Therapeutics the world's 7076th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Revance Therapeutics from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$0.66 B-45.27%
2023NZ$1.22 B-48.98%
2022NZ$2.39 B39.45%
2021NZ$1.71 B-34.37%
2020NZ$2.61 B107.09%
2019NZ$1.26 B13.75%
2018NZ$1.10 B-39.38%
2017NZ$1.83 B114.79%
2016NZ$0.85 B-39.65%
2015NZ$1.41 B174.68%
2014NZ$0.51 B

End of Day market cap according to different sources

On Nov 22nd, 2024 the market cap of Revance Therapeutics was reported to be:

NZ$0.66 Billion
by Nasdaq info icon info icon
NZ$0.66 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.17 B-73.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$637.80 B 95,377.96%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$39.28 B 5,780.38%๐Ÿ‡บ๐Ÿ‡ธ USA